Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 11/20 | 0.52 |
| ▸ | FAAH | O00519 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 5/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL458382 | 1.00 | MGLL (0.52) | MGLLFAAHMAPK1ALDH1A1TSHR | |
| SCHEMBL27650867 | 0.95 | MGLL (0.50) | MGLLFAAHMAPK1ALDH1A1TSHR | |
| SCHEMBL3759716 | 0.89 | MGLL (0.65) | MGLLFAAHMAPK1ALDH1A1TSHR | |
| SCHEMBL11410714 | 0.85 | MGLL (0.71) | MGLLFAAHMAPK1ALDH1A1TDP1 | |
| SCHEMBL5150580 | 0.79 | MGLL (0.52) | MGLLFAAHMAPK1ALDH1A1TDP1 | |
| SCHEMBL8467655 | 0.79 | HSP90AA1 (0.64) | MGLLFAAHMAPK1ALDH1A1TDP1 | |
| SCHEMBL4289963 | 0.79 | NPC1 (0.54) | MGLLFAAHMAPK1ALDH1A1TSHR | |
| SCHEMBL2696242 | 0.78 | MGLL (0.65) | MGLLFAAHMAPK1ALDH1A1TDP1 | |
| SCHEMBL2696243 | 0.78 | MGLL (0.65) | MGLLFAAHMAPK1ALDH1A1TDP1 | |
| SCHEMBL3665727 | 0.77 | MGLL (0.65) | MGLLFAAHMAPK1ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577563-B2 | Methods for multiplexing recombinase polymerase amplification | ABBOTT DIAGNOSTICS SCARBOROUGH, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| EP-4615966-A1 | METHODS AND COMPOSITIONS FOR PROCESSING AND AMPLIFICATION OF NUCLEIC ACIDS | Biomeme, Inc. (US) | 2025-09-17 | — | — | EP | disclosed |
| EP-4612326-A1 | COMPOSITIONS AND METHODS FOR THE DETECTION AND ANALYSIS OF HERPES SIMPLEX VIRUS 1 (HSV-1), HERPES SIMPLEX VIRUS 2 (HSV-2) AND VARICELLA ZOSTER VIRUS (VZV) | Abbott Molecular Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-4282961-B1 | COMPOSITIONS FOR THE DETECTION AND ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS | ABBOTT MOLECULAR INC (US) | 2025-08-20 | — | — | EP | disclosed |
| US-20250161948-A1 | PORTABLE DEVICES AND METHODS FOR ANALYZING SAMPLES | Biomeme, Inc. | 2025-05-22 | — | — | US | disclosed |
| US-20250121369-A1 | METHODS AND SYSTEMS FOR AUTOMATED SAMPLE PROCESSING | Biomeme, Inc. | 2025-04-17 | — | — | US | disclosed |
| US-20250093342-A1 | ANALYZING CELL SAMPLES | FIRST-CITIZENS BANK & TRUST COMPANY | 2025-03-20 | — | — | US | disclosed |
| US-20250085276-A1 | COMPOSITIONS AND METHODS FOR SERIAL TARGET DETECTION | FIRST-CITIZENS BANK & TRUST COMPANY | 2025-03-13 | — | — | US | disclosed |
| WO-2025049452-A1 | DEVICES AND METHODS FOR PROCESSING SAMPLES | Biomeme, Inc. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20240426815-A1 | SERIAL DETECTION OF MULTIPLE TARGETS | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-12-26 | — | — | US | disclosed |
| US-8273705-B2 | Conversion of apoptotic proteins | THE BURNHAM INSTITUTE (US) | 2012-09-25 | — | — | US | disclosed |
| US-20090215984-A1 | CONVERSION OF APOPTOTIC PROTEINS | THE BURNHAM INSTITUTE (US) | 2009-08-27 | — | — | US | disclosed |
| US-7491700-B2 | Conversion of apoptotic proteins | THE BURNHAM INSTITUTE (US) | 2009-02-17 | — | — | US | disclosed |
| US-20070117753-A1 | CONVERSION OF APOPTOTIC PROTEINS | THE BURNHAM INSTITUTE (US) | 2007-05-24 | — | — | US | disclosed |
| US-7176277-B2 | Conversion of apoptotic proteins | THE BURNHAM INSTITUTE (US) | 2007-02-13 | — | — | US | disclosed |
| US-20060193864-A1 | Conversion of apoptotic proteins | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2006-08-31 | — | — | US | disclosed |
| US-6994979-B2 | Conversion of apoptotic proteins | THE BURNHAM INSTITUTE (US) | 2006-02-07 | — | — | US | disclosed |
| US-20040220097-A1 | Conversion of apoptotic proteins | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-11-04 | — | — | US | disclosed |
| WO-2004052920-A9 | CONVERSION OF APOPTOTIC PROTEINS | BURNHAM INST (US) | 2004-08-19 | — | — | WO | disclosed |
| WO-2004052920-A2 | CONVERSION OF APOPTOTIC PROTEINS | THE BURNHAM INSTITUTE (US) | 2004-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577563-B2 | Methods for multiplexing recombinase polymerase amplification | POLL, POLM, DNMT3A | MGLL 3366/4885FAAH 4163/4885MAPK1 4154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.